• LAST PRICE
    2.0400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.0400/ 5
  • Ask / Lots
    2.0500/ 50
  • Open / Previous Close
    0.0000 / 2.0400
  • Day Range
    ---
  • 52 Week Range
    Low 1.3500
    High 3.8700
  • Volume
    38
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 8, 2024

      Show headlines and story abstract
    • 4:51PM ET on Wednesday May 08, 2024 by MT Newswires
      Companies Mentioned: SCYX
      04:51 PM EDT, 05/08/2024 (MT Newswires) -- ...
    • 4:30PM ET on Wednesday May 08, 2024 by GlobeNewswire
      Companies Mentioned: SCYX
    • 4:30PM ET on Wednesday May 08, 2024 by Dow Jones
      Companies Mentioned: SCYX

      ikoffler@lifesciadvisors.com
      SCYNEXIS, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data) Three Months Ended March 31, ---------------------------------- 2024 2023 Revenue: Product revenue, net $ -- $ 1,130 License agreement revenue 1,373 -- ------------ ----------- Total revenue 1,373 1,130 Operating expenses: Cost of product revenue -- 137 Research and development 7,212 6,835 Selling, general and administrative 3,669 4,840 ------------ ----------- Total operating expenses 10,881 11,812 Loss from operations (9,508) (10,682) Other (income) expense: Amortization of debt issuance costs and discount 401 255 Interest income (1,280) (587) Interest expense 205 1,447 Warrant liabilities fair value adjustment (9,608) 21,673 Derivative liabilities fair value adjustment (168) 406 ------------ ----------- Total other (income) expense (10,450) 23,194 ------------ ----------- Income (loss) before taxes 942 (33,876) Income tax expense (531) -- Net income (loss) $ 411 $ (33,876) ============ =========== Net income (loss) per share attributable to common stockholders -- basic Net income (loss) per share -- basic $ 0.01 $ (0.71) ============ =========== Net income (loss) per share attributable to common stockholders -- diluted Net income (loss) per share -- diluted $ 0.01 $ (0.71) ============ =========== Weighted average common shares outstanding -- basic and diluted Basic 48,245,559 47,757,246 ============ =========== Diluted 48,565,051 47,757,246 ============ =========== SCYNEXIS, INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) March 31, 2024 December 31, 2023 ---------------- --------------------- Assets Current assets: Cash and cash equivalents $ 35,482 $ 34,050 Short-term investments 44,762 40,312 Prepaid expenses and other current assets 1,583 5,548 License agreement receivable -- 2,463 License agreement contract asset 19,466 19,363 Restricted cash 380 380 Total current assets 101,673 102,116 ----------- -------------- Investments 13,943 23,594 Deferred offering costs 175 175 Restricted cash 163 163 Operating lease right-of-use asset 2,300 2,364 ----------- -------------- Total assets $ 118,254 $ 128,412 =========== ============== Liabilities and stockholders' equity Current liabilities: Accounts payable $ 8,918 $ 7,149 Accrued expenses 4,601 7,495 Deferred revenue, current portion 1,083 1,189 Operating lease liability, current portion 356 340 Warrant liabilities -- 130 Convertible debt and derivative liability 12,391 -- Total current liabilities 27,349 16,303 ----------- -------------- Deferred revenue 2,111 2,727 Warrant liabilities 12,202 21,680 Convertible debt and derivative liability -- 12,159 Operating lease liability 2,487 2,581 ----------- -------------- Total liabilities 44,149 55,450 ----------- -------------- Commitments and contingencies Stockholders' equity: Preferred stock, $0.001 par value, authorized 5,000,000 shares as of March 31, 2024 and December 31, 2023; 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023 -- -- Common stock, $0.001 par value, 150,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 37,779,796 and 37,207,799 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 41 40 Additional paid-in capital 428,900 428,169 Accumulated deficit (354,836) (355,247) ----------- -------------- Total stockholders' equity 74,105 72,962 ----------- -------------- Total liabilities and stockholders' equity $ 118,254 $ 128,412 =========== ==============
    • 4:30PM ET on Wednesday May 08, 2024 by Dow Jones
      Companies Mentioned: SCYX
  • Apr 30, 2024

Peers Headlines